Juan Paredes

1.2K posts

Juan Paredes banner
Juan Paredes

Juan Paredes

@johnepm

Gastroenterólogo del Hospital Nacional Guillermo Almenara Irigoyen Lima-Perú. Ex-Presidente de ASPEIN.

Lima Katılım Ekim 2010
1.8K Takip Edilen467 Takipçiler
Sabitlenmiş Tweet
Juan Paredes
Juan Paredes@johnepm·
Buenas tardes estimados amigos. Anunciamos la próxima realización del ECCO Workshop en Lima el 29 de agosto del 2025. Evento organizado por ASPEIN y ECCO. Gracias ⁦⁦@manu_barreiro
Juan Paredes tweet media
Español
3
9
33
3.7K
Juan Paredes retweetledi
Joaquín Rodríguez | 🔎Endoscopia digestiva
La IA en colonoscopia te hace peor endoscopista. No lo digo yo. Lo dice Lancet GH: el ADR cayó un 20% cuando quitaron la IA. Es la primera vez que se demuestra que la tecnología empeora resultados clínicos. Eso duele.
Español
2
8
35
2.7K
Juan Paredes
Juan Paredes@johnepm·
Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…
English
0
17
42
4.7K
Keith Siau
Keith Siau@drkeithsiau·
The difference between bloating and abdominal distention 💡
Keith Siau tweet media
English
6
66
207
9.4K
Juan Paredes retweetledi
Achintya Singh, MD
Achintya Singh, MD@AchintyaSinghMD·
Submucosal saline injection to differentiate T1a & T1b esophageal cancers? pmc.ncbi.nlm.nih.gov/articles/PMC12… 1⃣Staging accuracy improved from 68.5% to 84.8% 2⃣Studied Squamous cell cancers, predominantly upper esophagus 3⃣Conventional EUS: 15 patients with T1a were diagnosed as T1b
Achintya Singh, MD tweet mediaAchintya Singh, MD tweet media
English
2
12
42
2.5K
Juan Paredes retweetledi
UEGJ
UEGJ@UEGJournal·
🧩💊Anti-TNF therapy can induce #sarcoidosis-like lesions in #IBD GETAID series (59 centres, n=14): 🔸71% dyspnea | 50% cough/fever 🔸86% mediastinal adenopathy 🔸Steroids → remission (median 84 days) 🔸No recurrences at 40 mo 📖 #OpenAccess 👉 bit.ly/4rAAwtN
UEGJ tweet mediaUEGJ tweet mediaUEGJ tweet media
English
1
11
20
1.2K
Juan Paredes
Juan Paredes@johnepm·
Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…
English
0
6
10
1.2K
Beatriz Gros
Beatriz Gros@Bealoquebea·
Today I am presenting on behalf of @drshaunchuah and Nik Plevris the experience and first 3 months of chatibd.com a free AI multilingual IBD support for healthcare professionals
Beatriz Gros tweet media
English
4
16
52
2.3K
Juan Paredes
Juan Paredes@johnepm·
Effectiveness and safety of JAK inhibitors in acute severe ulcerative colitis: A systematic review and meta-analysis - Clinical Gastroenterology and Hepatology cghjournal.org/article/S1542-…
English
1
12
18
2.3K
Juan Paredes retweetledi
Intestinal Research
Intestinal Research@Intest_Res·
Association between anti-tumor necrosis factor alpha exposure and new-onset autoimmune diseases in inflammatory bowel disease: a nationwide case-control study in Korea doi.org/10.5217/ir.202…
Intestinal Research tweet media
English
1
11
23
1.6K
Juan Paredes retweetledi
Beatriz Gros
Beatriz Gros@Bealoquebea·
🧵 Can past response to steroids predict future response in patients with UC? We tried to answer a question clinicians face every day—but that has surprisingly little data behind it
Beatriz Gros tweet media
English
3
18
56
2.8K
Juan Paredes retweetledi
Pilar Nos
Pilar Nos@pilarnos·
La enfermedad inflamatoria intestinal es mi vida profesional. GETECCU me dio una comunidad, los pacientes un proposito. Y algo aún más valioso: amistad, lealtad, trabajo en equipo.. yo solo puedo decir gracias. Esta comunidad y estas personas han marcado mi vida para siempre. 🥰
Pilar Nos tweet media
Español
3
6
55
3.2K
Juan Paredes
Juan Paredes@johnepm·
Comparative Effectiveness of Infliximab vs Ustekinumab for Endoscopic and Transmural Remission in Biologic Naïve Crohn’s Disease - Clinical Gastroenterology and Hepatology cghjournal.org/article/S1542-…
Română
0
12
38
3.4K